FDA Clears New Digital Radiography System
By Medimaging International staff writers
Posted on 08 May 2017
Image: The GC70 DR system, intended for pediatric and adult patients (Photo courtesy of Samsung NeuroLogica).
A new digital radiography system, intended for pediatric and adult patients, and featuring a new imaging engine, and workflow improvements, has received FDA 510(k) clearance from the US FDA.
The Digital Radiography (DR) system is the newest addition to a portfolio of DR systems from the same medical imaging vendor.
The GC70 DR system is manufactured by Samsung NeuroLogica and features the S-Vue imaging engine with adaptive filtering and other digital enhancements. The GC70 also includes many workflow enhancements, such as S-Align that can provide accurate alignment at multiple angles including proper radiographic alignment for wheel chair and gurney patients, which can save time during diagnostic procedures. Radiation dose for pediatric chest exams is also reduced to a minimum by the use of an innovative four-axis, individual blade control collimation function.
Optional features of the new system include SimGrid for enhanced contrast, S-Guide for simplifying stitching settings, SmartStitching for viewing a large stitched image, Bone Suppression Imaging (BSI) for imaging of lung tissue, and wireless S-Detectors in multiple sizes.
Philip Sullivan, President and CEO of Samsung NeuroLogica, said, “The GC70 is leading a new generation of digital radiography systems that will make X-Rays safer and healthcare more efficient for both patients and care providers. With FDA clearance of the GC70 and the GM85, health systems have two powerful new options for inpatient and ambulatory settings that represent affordability with quality care.”